Compounds > celecoxib

celecoxib and deracoxib

celecoxib has been researched along with deracoxib in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Bertenshaw, SR; Burton, EG; Carter, JS; Cogburn, JN; Collins, PW; Docter, S; Graneto, MJ; Gregory, SA; Isakson, PC; Koboldt, CM; Lee, LF; Malecha, JW; Miyashiro, JM; Penning, TD; Perkins, WE; Rogers, RS; Rogier, DJ; Seibert, K; Talley, JJ; Veenhuizen, AW; Yu, SS; Zhang, YY1
Baurin, N; Chavatte, P; Lesieur, D; Marot, C; Yous, S1
Bronk, BS; Callaghan, KM; Cheng, H; Crosson, RM; DeMello, KM; Dutra, JK; Haven, ML; Jaynes, BH; Kilroy, C; Kirk, GW; Kolosko, NL; Koss, DA; Li, C; Li, J; Lund, LA; Lynch, MP; Mann, DW; Minich, ML; Morton, BJ; Nimz, EL; Petras, CF; Rafka, RJ; Rast, B; Sakya, SM; Seibel, SB; Shavnya, A; Silvia, A; Ziegler, CB1
Hill, K; Meisner, A; Schaefer, M; Spyra, S1
Hu, XG; Jiang, W; Pang, JY; Wan, C; Zhang, XW1

Other Studies

5 other study(ies) available for celecoxib and deracoxib

ArticleYear
Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).
    Journal of medicinal chemistry, 1997, Apr-25, Volume: 40, Issue:9

    Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Carrageenan; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Hyperalgesia; Isoenzymes; Magnetic Resonance Spectroscopy; Male; Membrane Proteins; Molecular Structure; Osteoarthritis; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Structure-Activity Relationship; Sulfonamides

1997
Three-dimensional quantitative structure-activity relationships of cyclo-oxygenase-2 (COX-2) inhibitors: a comparative molecular field analysis.
    Journal of medicinal chemistry, 2001, Sep-27, Volume: 44, Issue:20

    Topics: Benzene Derivatives; Binding Sites; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cyclopentanes; Imidazoles; Isoenzymes; Isoxazoles; Models, Molecular; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Pyrroles; Quantitative Structure-Activity Relationship; Spiro Compounds; Thiophenes

2001
Discovery of a potent, selective and orally active canine COX-2 inhibitor, 2-(3-difluoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonyl-pyridine.
    Bioorganic & medicinal chemistry letters, 2004, Jan-05, Volume: 14, Issue:1

    Topics: Administration, Oral; Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dogs; Isoenzymes; Prostaglandin-Endoperoxide Synthases; Pyridines; Structure-Activity Relationship

2004
COX-2-selective inhibitors celecoxib and deracoxib modulate transient receptor potential vanilloid 3 channels.
    British journal of pharmacology, 2017, Volume: 174, Issue:16

    Topics: Animals; Boron Compounds; Celecoxib; Cell Line; Cyclooxygenase 2 Inhibitors; HEK293 Cells; Hot Temperature; Humans; Keratinocytes; Mice; Sulfonamides; TRPV Cation Channels

2017
Copper-Catalyzed Reductive Ring-Cleavage of Isoxazoles: Synthesis of Fluoroalkylated Enaminones and Application for the Preparation of Celecoxib, Deracoxib, and Mavacoxib.
    The Journal of organic chemistry, 2021, 03-19, Volume: 86, Issue:6

    Topics: Catalysis; Celecoxib; Copper; Isoxazoles; Pyrazoles; Sulfonamides

2021